Cargando…
P789: EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN (IPTA) MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH THE ANTI-C5 MONOCLONAL ANTIBODY (MAB) TESIDOLUMAB (TESI)
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430731/ http://dx.doi.org/10.1097/01.HS9.0000970060.17022.e8 |
| _version_ | 1785091036686581760 |
|---|---|
| author | Ando, Kiyoshi Griškevičius, Laimonas Ikezoe, Takayuki Ito, Yoshikazu Masuko, Masayoshi Ueda, Yasutaka Bagger, Morten Danekula, Rambabu Rozenberg, Izabela Junge, Guido Mayer, Jiri |
| author_facet | Ando, Kiyoshi Griškevičius, Laimonas Ikezoe, Takayuki Ito, Yoshikazu Masuko, Masayoshi Ueda, Yasutaka Bagger, Morten Danekula, Rambabu Rozenberg, Izabela Junge, Guido Mayer, Jiri |
| author_sort | Ando, Kiyoshi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430731 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104307312023-08-17 P789: EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN (IPTA) MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH THE ANTI-C5 MONOCLONAL ANTIBODY (MAB) TESIDOLUMAB (TESI) Ando, Kiyoshi Griškevičius, Laimonas Ikezoe, Takayuki Ito, Yoshikazu Masuko, Masayoshi Ueda, Yasutaka Bagger, Morten Danekula, Rambabu Rozenberg, Izabela Junge, Guido Mayer, Jiri Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430731/ http://dx.doi.org/10.1097/01.HS9.0000970060.17022.e8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Ando, Kiyoshi Griškevičius, Laimonas Ikezoe, Takayuki Ito, Yoshikazu Masuko, Masayoshi Ueda, Yasutaka Bagger, Morten Danekula, Rambabu Rozenberg, Izabela Junge, Guido Mayer, Jiri P789: EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN (IPTA) MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH THE ANTI-C5 MONOCLONAL ANTIBODY (MAB) TESIDOLUMAB (TESI) |
| title | P789: EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN (IPTA) MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH THE ANTI-C5 MONOCLONAL ANTIBODY (MAB) TESIDOLUMAB (TESI) |
| title_full | P789: EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN (IPTA) MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH THE ANTI-C5 MONOCLONAL ANTIBODY (MAB) TESIDOLUMAB (TESI) |
| title_fullStr | P789: EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN (IPTA) MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH THE ANTI-C5 MONOCLONAL ANTIBODY (MAB) TESIDOLUMAB (TESI) |
| title_full_unstemmed | P789: EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN (IPTA) MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH THE ANTI-C5 MONOCLONAL ANTIBODY (MAB) TESIDOLUMAB (TESI) |
| title_short | P789: EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN (IPTA) MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH THE ANTI-C5 MONOCLONAL ANTIBODY (MAB) TESIDOLUMAB (TESI) |
| title_sort | p789: efficacy and safety of switching to iptacopan (ipta) monotherapy in patients with paroxysmal nocturnal hemoglobinuria (pnh) treated with the anti-c5 monoclonal antibody (mab) tesidolumab (tesi) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430731/ http://dx.doi.org/10.1097/01.HS9.0000970060.17022.e8 |
| work_keys_str_mv | AT andokiyoshi p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi AT griskeviciuslaimonas p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi AT ikezoetakayuki p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi AT itoyoshikazu p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi AT masukomasayoshi p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi AT uedayasutaka p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi AT baggermorten p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi AT danekularambabu p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi AT rozenbergizabela p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi AT jungeguido p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi AT mayerjiri p789efficacyandsafetyofswitchingtoiptacopaniptamonotherapyinpatientswithparoxysmalnocturnalhemoglobinuriapnhtreatedwiththeantic5monoclonalantibodymabtesidolumabtesi |